Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 6/20 | 1.00 |
| ▸ | MAOB | P27338 | 3/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 1.00 |
| ▸ | CALM1 | P0DP23 | 2/20 | 1.00 |
| ▸ | PKM | P14618 | 2/20 | 1.00 |
| ▸ | FTO | Q9C0B1 | 2/20 | 1.00 |
| ▸ | CA12 | O43570 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 2/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 1.00 |
| ▸ | CA9 | Q16790 | 2/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | HSD17B1 | P14061 | 1/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 1/20 | 1.00 |
| ▸ | HSD17B3 | P37058 | 1/20 | 1.00 |
| ▸ | XDH | P47989 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 5/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 7-Hydroxyflavone SCHEMBL29678183 | 1.00 | CYP19A1 (1.00) | CYP19A1MAOBMAOACALM1PKM | |
| 7-Hydroxyflavone SCHEMBL10808394 | 0.98 | CYP19A1 (0.97) | CYP19A1MAOBMAOACALM1PKM | |
| 7-Hydroxyflavone SCHEMBL27789687 | 0.98 | CYP19A1 (0.97) | CYP19A1MAOBMAOACALM1PKM | |
| 7-Hydroxyflavone SCHEMBL27889515 | 0.94 | CYP19A1 (0.89) | CYP19A1MAOBMAOACALM1PKM | |
| 7-Hydroxyflavone SCHEMBL31035954 | 0.94 | CYP19A1 (0.89) | CYP19A1MAOBMAOACALM1PKM | |
| Flavone SCHEMBL3515129 | 0.93 | CYP19A1 (0.86) | CYP19A1MAOBMAOACALM1PKM | |
| SCHEMBL31167385 | 0.90 | CYP3A4 (1.00) | CYP19A1MAOBMAOACALM1PKM | |
| SCHEMBL157723 | 0.90 | CYP3A4 (1.00) | CYP19A1MAOBMAOACALM1PKM | |
| SCHEMBL3135989 | 0.89 | CYP3A4 (1.00) | CYP19A1MAOBMAOACALM1PKM | |
| SCHEMBL31675776 | 0.89 | CYP3A4 (1.00) | CYP19A1MAOBMAOACALM1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 610 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504681-A | Coke-reducing and thorn-reducing aroma-suppressing compound, preparation method, application and application method | 河南中烟工业有限责任公司 | 2025-02-25 | — | — | CN | claimed |
| US-20240285660-A1 | COMPOSITION FOR WOUND RELIEF AND INHIBITING A PHD PROTEIN AND METHODS OF TREATMENT | CURAPEP LLC (US) | 2024-08-29 | — | — | US | claimed |
| CN-118141800-A | Application of 7-hydroxyflavone in preparing medicament for preventing and treating obesity and fatty liver | 广西大学 | 2024-06-07 | — | — | CN | claimed |
| CN-116445323-A | Bacillus bailii capable of antagonizing growth of toxigenic mold and degrading vomitoxin and application thereof | 广西优比特生物科技有限公司 | 2023-07-18 | — | — | CN | claimed |
| US-20230119060-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE | MEDIENCE CO., LTD. (KR) | 2023-04-20 | — | — | US | claimed |
| CN-115778836-A | Essential oil composition for scalp care and preparation method thereof | 北京普世安生物科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-20220362260-A1 | METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET | MAGI EUREGIO SCS (IT) | 2022-11-17 | — | — | US | claimed |
| WO-2022232243-A1 | COMPOSITIONS FOR WOUND RELIEF AND INHIBITING A PHD PROTEIN AND METHODS OF TREATMENT | CURAPEP LLC (US) | 2022-11-03 | — | — | WO | claimed |
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2022-09-08 | — | — | US | claimed |
| US-20220249431-A1 | ANTIMYCOTIC | Karl-Franzens-Universität Graz (AT) | 2022-08-11 | — | — | US | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| WO-2000012496-A1 | NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE | LG CHEMICAL LTD. (KR) | 2000-03-09 | — | — | WO | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0620918-B1 | CARBON DIOXIDE DETECTOR | JOHNSON & JOHNSON PROFESSIONAL (GB) | 1997-07-30 | — | — | EP | claimed |
| WO-1996031206-A2 | FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1996-10-10 | — | — | WO | claimed |
| US-5480611-A | Carbon dioxide detector | GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC. | 1996-01-02 | — | — | US | claimed |
| EP-0620918-A1 | CARBON DIOXIDE DETECTOR. | JOHNSON & JOHNSON PROFESSIONAL (GB) | 1994-10-26 | — | — | EP | claimed |
| WO-1993014399-A1 | CARBON DIOXIDE DETECTOR | JOHNSON & JOHNSON PROFESSIONAL PRODUCTS LTD. (GB) | 1993-07-22 | — | — | WO | claimed |
| US-4807237-A | Method and apparatus for operating a dye laser with a proton transfer reaction | Max-Planck -Gesellschaft zur Forderung der Wissenschaften e.V. (DE) | 1989-02-21 | — | — | US | claimed |
| US-4758678-A | Preparation of 7-(2,3-epoxypropoxy)flavone | PENNWALT CORPORATION (US) | 1988-07-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | ITGA8, ITGAL, ITGB2 | CYP19A1 2742/4885MAOB 608/4885MAOA 871/4885 |
| US-20220249431-A1 | ANTIMYCOTIC | ETF1, FOXM1, RIF1 | CYP19A1 3735/4885MAOB 729/4885MAOA 916/4885 |
| US-20230119060-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE | SLC5A2, SLC5A1, SLC5A6 | CYP19A1 2295/4885MAOB 1565/4885MAOA 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.